AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. KRYS
  4. [Form 4] Krystal Biotech, Inc. Insider Trading Activity

[Form 4] Krystal Biotech, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4

Filing content is currently unavailable.

Source:

Stock KRYS logo
Krystal Biotech

NASDAQ:KRYS

KRYS Rankings

#1484 Ranked by Market Cap
N/A Ranked by Dividends

KRYS Latest News

Aug 21, 2025
Krystal Biotech Announces Update on Development Plans for Oncology Program KB707 and Prioritization of Inhaled KB707 for the Treatment of Non-Small Cell Lung Cancer
Aug 4, 2025
Krystal Biotech Announces Second Quarter 2025 Financial and Operating Results
Jul 29, 2025
Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025
Jul 25, 2025
Krystal Biotech Announces Approval of VYJUVEK® by Japan’s Ministry of Health, Labour and Welfare for the Treatment of Dystrophic Epidermolysis Bullosa
Jul 24, 2025
Jeune Announces Positive Results and Significant Aesthetic Improvements from Phase 1 Study of KB304 for Moderate to Severe Wrinkles of the Décolleté

KRYS Latest SEC Filings

Aug 4, 2025
[8-K] Krystal Biotech, Inc. Reports Material Event
Aug 4, 2025
[10-Q] Krystal Biotech, Inc. Quarterly Earnings Report
Jul 25, 2025
[8-K] Krystal Biotech, Inc. Reports Material Event
Jul 24, 2025
[8-K] Krystal Biotech, Inc. Reports Material Event
Jul 16, 2025
[Form 4] Krystal Biotech, Inc. Insider Trading Activity

KRYS Stock Data

4.17B
24.80M
11.86%
104.2%
11.74%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
PITTSBURGH